Corpus Intelligence IC Memo — DELTA MEDICAL CENTER MEMPHIS 2026-04-26 13:28 UTC
IC Memo — DELTA MEDICAL CENTER MEMPHIS
Investment Committee Memorandum | TN | 10 beds | Grade D | EBITDA uplift $2.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

DELTA MEDICAL CENTER MEMPHIS

CCN 440159 | SHELBY, TN | 10 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

DELTA MEDICAL CENTER MEMPHIS is a 10-bed community hospital in SHELBY, TN with $28.4M in net patient revenue and a 3.4% operating margin. The hospital serves a payer mix of 0.0% Medicare, 0.0% Medicaid, and 100.0% commercial.

Thesis: Turnaround. Our ML models identify $2.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.4% to 10.8% (+736bps).

Net Revenue HCRIS$28.4M
Current EBITDA COMPUTED$964K
Operating Margin COMPUTED3.4%
Occupancy HCRIS0.1%
Revenue / Bed COMPUTED$2.8M
Net-to-Gross HCRIS44.4%
Distress Probability MLnan%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
9
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 3.4% places it above the state median. Among 9 size-comparable peers (5-20 beds), the median margin is -7.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (5-20), prioritizing same-state peers. 9 hospitals in the comp set.

HospitalStateBedsRevenueMargin
DELTA MEDICAL CENTER MEMPHIS (Target)TN10$28.4M3.4%
TRUSTPOINT HOSPITALTN18$50.8M-0.8%
SAINT THOMAS HIGHLAND HOSPITALTN12$21.5M-11.9%
RIDGEVIEW PSYCHIATRIC HOSPITALTN16$11.7M-46.4%
ST THOMAS DEKALB HOSPITALTN18$10.8M-32.3%
HANCOCK COUNTY HOSPITALTN10$7.2M-7.9%
BEHAVORIAL HEALTH CENTERSTN16$4.6M-0.9%
BEHAVIORAL HEALTH CENTERSTN16$4.4M8.2%
BEHAVORIAL HEALTHCARE CENTERSTN16$4.4M11.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$596K+210bp18mo
Cost to Collect4.5%2.5%$568K+200bp12mo
Denial Rate Reduction12.0%6.5%$562K+198bp12mo
A/R Days Reduction5200.0%3800.0%$345K+122bp9mo
Clean Claim Rate88.0%96.0%$18K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$596K
Cost to Collect
$568K
Denial Rate Reduction
$562K
A/R Days Reduction
$345K
Clean Claim Rate
$18K
Total EBITDA Uplift$2.1M
Current EBITDA$964K
+ RCM Uplift+$2.1M
Pro Forma EBITDA$3.1M
Current Margin3.4%
Pro Forma Margin10.8%
WC Released (1x)$1.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.5M$27.3M18.38x79.0%
Base (11x exit)10.0x11.0x$1.5M$30.5M20.54x83.0%
Bull Case9.0x11.0x$1.3M$37.8M28.35x95.2%
Bull (12x exit)9.0x12.0x$1.3M$41.7M31.23x99.0%
Bear Case11.0x10.0x$1.6M$16.3M10.01x58.5%
Bear (11x exit)11.0x11.0x$1.6M$18.5M11.33x62.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 0.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 9 hospitals with 5-20 beds
  • Same-state prioritization (n=12)
  • Comp margins: P25=-32.3% / P50=-7.9% / P75=-0.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.